Business Summary
Metabolic Solutions Development Company LLC is a United States-based drug discovery and development company. The Company develops therapies for metabolic diseases associated with altered mitochondrial function, insulin resistance and type 2 diabetes. Its products, MSDC-0160 and MSDC-0602, are the anti-diabetic agents in a class of insulin sensitizers characterized as mTOT Modulators for the treatment of type 2 diabetes. The Company is developing a class of oral insulin sensitizers that improve insulin action, as well as improve lipid profiles, increase brown fat, and preserve -cells.
Country of Incorporation
United States of America
Incorporation Date
2011-06-15
Business Sector
Pharmaceuticals & Medical Research
Company Address
161 E Michigan Ave., 4th Floor